Magnetar Financial LLC Seagen Inc. Transaction History

Magnetar Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $4.01 Million - $4.53 Million	20,958 Added 6.38%	349,204 $74.1 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $8.58 Million - $9.43 Million	45,713 Added 16.18%	328,246 $63.2 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $36 Million - $57.4 Million	282,533 New	282,533 $57.2 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $637,844 - $1.05 Million	-5,862 Reduced 65.36%	3,107 $550,000
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $1.07 Million - $1.42 Million	8,969 New	8,969 $1.29 Million

Q2 2021 Aug 06, 2021	SELL	$135.08 - $161.1 $2.57 Million - $3.06 Million	-19,009 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $2.61 Million - $3.63 Million	19,009 New	19,009 $2.64 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.